Clik here to view.
Mauna Kea Technologies Announces Strong Presence at Asia-Pacific Digestive...
PARIS & SHANGHAI Regulatory News: Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer,...
View ArticleClik here to view.
Oral-B® Announces Launch of New Digital Tool for Better Oral Care
CINCINNATI Oral-B today announced the launch of the Oral-B App, a breakthrough digital tool for brushing routines that gives users a new kind of personal power over their oral care. Connecting with...
View ArticleClik here to view.
不断增加的证据库支持V.A.C. VeraFlo™ 疗法正在改变医生治疗伤口的方式
圣安东尼奥 (美国商业资讯) — Kinetic Concepts, Inc.今天发布了新出现的临床和科学证据，这些证据支持，V.A.C. VeraFlo™ 滴灌疗法 (NPWTi)与传统.A.C.® 疗法 (NPWT)相比更加有效。这些研究显示，V.A.C. VeraFlo™...
View ArticleClik here to view.
3D White推出夏奇拉《微笑故事》短片
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 西班牙巴塞罗那 (美国商业资讯) –(NYSE: PG)佳洁士和欧乐B 3D White今天发布全球行动倡议，邀请全球粉丝分享笑容的力量和故事。这场全球活动在西班牙巴塞罗那举行的佳洁士和欧乐B蓝白盛典(Crest & Oral-B Blue & White...
View ArticleClik here to view.
CORRECTING and REPLACING Takeda Announces 118 Abstracts on VELCADE®...
OSAKA, Japan Please replace the release dated November 11, 2013 with the following correction version due to multiple revisions. The corrected release reads: TAKEDA ANNOUNCES 118 ABSTRACTS ON...
View ArticleClik here to view.
3DホワイトがシャキーラのSmileStoryを発表
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 スペイン・バルセロナ （ビジネスワイヤ） —...
View ArticleClik here to view.
エリテックが急性骨髄性白血病における第IIb相試験の肯定的なDSMB評価結果を発表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（NYSE Euronext Paris: FR0011471135 –...
View ArticleClik here to view.
Life Stem Genetics Announces LOI with Stem Cell Therapy Clinic in Dhaka,...
BEVERLY HILLS, Calif. Life Stem Genetics, Inc. (OTCBB:LIFS) (the“Company”) announces the signing of a Letter of Intent (“LOI”) between Life Stem Genetics, Inc. and Dr. Iqram Rahman (“IR”) in Dhaka,...
View ArticleClik here to view.
V.A.C. VeraFlo™ Therapyが臨床医の創傷治療手法に変革をもたらすことを支持する証拠が相次ぐ
サンアントニオ （ビジネスワイヤ） — キネティック・コンセプツは本日、従来のV.A.C.®療法（NPWT）と比較したV.A.C. VeraFlo™ Instillation Therapy（NPWTi）の有効性を支持する新たな臨床的・科学的証拠が現れたと発表しました。複数の試験において、従来のNPWTと比較してV.A.C. VeraFlo™...
View ArticleClik here to view.
万灵科制药与华润医药（上海）有限公司 在中国达成共同推广安射力X射线造影剂（碘佛醇注射液）的合作安排
中华人民共和国, 上海（日期） 万灵科制药今天宣布了一项与华润医药（上海）有限公司在中华人民共和国合作推广X射线造影剂产品 –安射力（碘佛醇注射液）的安排。 万灵科制药国际业务运营总监麦立恒表示: 万灵科期望通过此次与华润医药的合作，进一步增强万灵科在中国日益增长的造影产品领域的持续努力。本次合作所涉及的造影剂产品将被广泛用于X射线检查、计算机图像扫描，以及心血管手术等医疗相关领域。...
View ArticleClik here to view.
Cisbio Bioassays, in Partnership with Argos Soditic, Makes a Major Step...
PARIS & CODOLET, France The funds managed by Argos Soditic announce the acquisition, together with the management, of Cisbio Bioassays. This cutting-edge biotechnology company is the leader in...
View ArticleClik here to view.
Cisbio Bioassays与Argos Soditic携手合作，迈出向前发展的关键一步
法国巴黎和科多莱 (美国商业资讯)–Argos Soditic管理下的基金宣布与Cisbio Bioassays管理层携手收购Cisbio Bioassays。Cisbio Bioassays是一家尖端生物技术公司，它是体外诊断和制药研究产品及服务领域中的领先企业。 通过这一管理层收购(MBO)操作，Cisbio Bioassays从比利时IBA集团中分拆，成为独立公司。...
View ArticleClik here to view.
シスビオ・バイオアッセイズがアルゴス・ソディティックと共に開発活動を促進
パリ、仏コドレ （ビジネスワイヤ） — アルゴス・ソディティックが運用するファンドは、シスビオ・バイオアッセイズを経営陣と共に買収すると発表しました。シスビオ・バイオアッセイズは最先端のバイオテクノロジー企業であり、ヒト体外診断・薬剤研究分野の大手です。 シスビオ・バイオアッセイズは、このマネジメント・バイアウト（MBO）を通じて独立し、スピンオフとしてベルギーのIBAグループを離れます。...
View ArticleClik here to view.
HD Medical Debuts ViScope MD World’s First Visual Stethoscope with Murmur...
DÜSSELDORF, Germany Today at MEDICA in Hall 16 / A05(7), HD Medical Inc. debuts its groundbreaking visual stethoscope ViScope MD™ featuring the world’s first murmur detection indicator. This...
View ArticleClik here to view.
Vancive Medical Technologies™与CareFusion签订抗微生物敷料协议
芝加哥 (美国商业资讯)–Vancive Medical Technologies™ 与CareFusion Corporation (NYSE:CFN)今天宣布签订一项排他性协议，涉及在美国、加拿大和墨西哥授权和分销Vancive 用于血管通路的BeneHold™葡萄糖酸氯己定(CHG)抗微生物粘贴技术。...
View ArticleClik here to view.
Agilent Technologies to Collaborate with University of Queensland on Oral...
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced it will collaborate with the University of Queensland Centre for Clinical Research in Brisbane, Australia, to increase...
View ArticleClik here to view.
Cytori Comments on New Legislation for Regenerative Medicine in Japan
SAN DIEGO Cytori Therapeutics (NASDAQ: CYTX) reports that on November 20, 2013, the Japanese legislature (Diet) approved new legislation targeted at regenerative medicine therapies. The Regenerative...
View ArticleClik here to view.
CardioPharma Triple Combination CVD Capsule Shows Bioequivalence
WILMINGTON, N.C. The lead product for CardioPharma, a patented triple-combination once-daily Cardiovascular Disease (CVD) capsule, has successfully completed the FDA required pharmacokinetic study....
View ArticleClik here to view.
Teleflex Responds to Haiyan Disaster Relief Efforts
LIMERICK, Pa. Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, today announced an initial donation of $25,000 in support of disaster...
View ArticleClik here to view.
Australian Motion Analysis Pioneer, dorsaVi Ltd, Launches $18M Initial Public...
MELBOURNE, Australia dorsaVi Ltd, an Australian-based company specialising in the development and commercialisation of wireless and wearable sensor movement monitoring products, has issued a...
View Article